As the prospect of sector-specific tariffs under the second Trump administration continues to rattle drugmakers, a more ...

One of the FDA’s recently departed top officials is weighing in on the wide-ranging staff cuts at the agency and how they ...

Trump administration cuts across federal health agencies have sent shivers through a biotech industry already struggling ...

The health secretary is frequently returning to rhetoric from his time as one of the nation's most prominent vaccine critics.

Bank of America Securities analyst Alec Stranahan maintained a Hold rating on Novavax (NVAX – Research Report) today and set a price target of ...

Yesterday, the US Centers for Disease Control and Prevention (CDC) issued a level 2 travel notice (practice enhanced ...

Pfizer Inc.'s stock is trading at $22 with an 8% dividend yield, driven by market fears over losing vaccine revenues. Read ...

The advisory committee, which met Tuesday for the first time since Robert F. Kennedy Jr. was sworn in as health secretary, ...

In the wake of unprecedented workforce cuts at the FDA, former Commissioner Scott Gottlieb and an unnamed former CBER ...

An advisory panel on vaccines meets, carefully, in the shadow of a health secretary who has often criticized it.

As in previous studies, the SHIELD study found health care workers who received the Novavax vaccine reported significantly ...